Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin

Pharmacogenomics J. 2003;3(4):202-14. doi: 10.1038/sj.tpj.6500182.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Cytochrome P-450 Enzyme System / genetics*
  • Hemorrhage / ethnology
  • Hemorrhage / etiology
  • Hemorrhage / genetics
  • Humans
  • Metabolic Clearance Rate / genetics
  • Pharmacogenetics*
  • Polymorphism, Genetic*
  • Warfarin / administration & dosage
  • Warfarin / pharmacokinetics
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Warfarin
  • Cytochrome P-450 Enzyme System